ESC 365 - Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation

ESC Premium Access

Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation

Session: Highlights from the Young in atrial fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor J. Dickow (Hamburg, DE)

Event: ESC Congress 2021 - The Digital Experience

Congress Session

About the speaker

Doctor Jannis Dickow

University Heart & Vascular Center Hamburg, Hamburg (Germany)

1 presentation

0 follower

3 more presentations in this session

Acute change in parasympathetic cardiac innervation after pulmonary vein isolation by pulse-field and radiofrequency energy

Speaker: Doctor P. Stojadinovic (Prague, CZ)

The association of stroke rate with low density lipoprotein and statin exposure in patients with atrial fibrillation (AF)

Speaker: Doctor B. Shweikialrefaee (Toronto, CA)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation

Speaker: Doctor N. Habel (Burlington, US)

Access the full session

Highlights from the Young in atrial fibrillation

Speakers: Doctor J. Dickow, Doctor P. Stojadinovic, Doctor B. Shweikialrefaee, Doctor N. Habel

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

ESC Premium Access

Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation

27 August 2021

ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

27 August 2021

This platform is supported by